237 related articles for article (PubMed ID: 16146758)
1. The KISS1 metastasis suppressor: mechanistic insights and clinical utility.
Nash KT; Welch DR
Front Biosci; 2006 Jan; 11():647-59. PubMed ID: 16146758
[TBL] [Abstract][Full Text] [Related]
2. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.
Nash KT; Phadke PA; Navenot JM; Hurst DR; Accavitti-Loper MA; Sztul E; Vaidya KS; Frost AR; Kappes JC; Peiper SC; Welch DR
J Natl Cancer Inst; 2007 Feb; 99(4):309-21. PubMed ID: 17312308
[TBL] [Abstract][Full Text] [Related]
3. KISS1 metastasis suppression and emergent pathways.
Harms JF; Welch DR; Miele ME
Clin Exp Metastasis; 2003; 20(1):11-8. PubMed ID: 12650602
[TBL] [Abstract][Full Text] [Related]
4. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells.
Beck BH; Welch DR
Eur J Cancer; 2010 May; 46(7):1283-9. PubMed ID: 20303258
[TBL] [Abstract][Full Text] [Related]
5. Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer.
Sun YB; Xu S
Int J Oncol; 2013 Aug; 43(2):521-30. PubMed ID: 23716269
[TBL] [Abstract][Full Text] [Related]
6. From KISS1 to kisspeptins: An historical perspective and suggested nomenclature.
Gottsch ML; Clifton DK; Steiner RA
Peptides; 2009 Jan; 30(1):4-9. PubMed ID: 18644415
[TBL] [Abstract][Full Text] [Related]
7. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha.
Jiang Y; Berk M; Singh LS; Tan H; Yin L; Powell CT; Xu Y
Clin Exp Metastasis; 2005; 22(5):369-76. PubMed ID: 16283480
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10.
Martínez-Fuentes AJ; Molina M; Vázquez-Martínez R; Gahete MD; Jiménez-Reina L; Moreno-Fernández J; Benito-López P; Quintero A; de la Riva A; Diéguez C; Soto A; Leal-Cerro A; Resmini E; Webb SM; Zatelli MC; degli Uberti EC; Malagón MM; Luque RM; Castaño JP
Eur J Endocrinol; 2011 Mar; 164(3):355-62. PubMed ID: 21169415
[TBL] [Abstract][Full Text] [Related]
9. KISS1/KISS1R and Breast Cancer: Metastasis Promoter.
Guzman S; Brackstone M; Wondisford F; Babwah AV; Bhattacharya M
Semin Reprod Med; 2019 Jul; 37(4):197-206. PubMed ID: 31972865
[TBL] [Abstract][Full Text] [Related]
10. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and functional characterization of the kisspeptin/kisspeptin receptor system in lower vertebrates.
Biran J; Ben-Dor S; Levavi-Sivan B
Biol Reprod; 2008 Oct; 79(4):776-86. PubMed ID: 18509165
[TBL] [Abstract][Full Text] [Related]
13. The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review).
Ji K; Ye L; Mason MD; Jiang WG
Int J Mol Med; 2013 Oct; 32(4):747-54. PubMed ID: 23969598
[TBL] [Abstract][Full Text] [Related]
14. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
15. A role for kisspeptin in islet function.
Hauge-Evans AC; Richardson CC; Milne HM; Christie MR; Persaud SJ; Jones PM
Diabetologia; 2006 Sep; 49(9):2131-5. PubMed ID: 16826407
[TBL] [Abstract][Full Text] [Related]
16. KiSS1 in regulation of metastasis and response to antitumor drugs.
Corno C; Perego P
Drug Resist Updat; 2019 Jan; 42():12-21. PubMed ID: 30776659
[TBL] [Abstract][Full Text] [Related]
17. KISS1 and KISS1R expression in primary and metastatic colorectal cancer.
Matthaiou S; Kostakis ID; Kykalos S; Machairas N; Spartalis E; Ntikoudi E; Lambropoulou M; Karayiannakis A; Machairas N
J BUON; 2018; 23(3):598-603. PubMed ID: 30003725
[TBL] [Abstract][Full Text] [Related]
18. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
19. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
Wang CH; Qiao C; Wang RC; Zhou WP
Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
[TBL] [Abstract][Full Text] [Related]
20. The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma.
Navenot JM; Evans B; Oishi S; Setsuda S; Fujii N; Peiper SC
Melanoma Res; 2012 Apr; 22(2):140-50. PubMed ID: 22395416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
